Frontiers in Immunology (Jun 2021)

An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells

  • James Davies,
  • Andres F. Vallejo,
  • Sofia Sirvent,
  • Gemma Porter,
  • Kalum Clayton,
  • Yamkela Qumbelo,
  • Patrick Stumpf,
  • Patrick Stumpf,
  • Jonathan West,
  • Jonathan West,
  • Clive M. Gray,
  • Nyaradzo T. L. Chigorimbo-Murefu,
  • Ben MacArthur,
  • Ben MacArthur,
  • Marta E. Polak,
  • Marta E. Polak

DOI
https://doi.org/10.3389/fimmu.2021.665312
Journal volume & issue
Vol. 12

Abstract

Read online

Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments.

Keywords